
UNH
UnitedHealth Group Incorporated · NYSE
$512.60+0.97%
9 Sep close- Market cap
- $472B
- Sector
- Health care
Income statement
Revenue, costs and earnings
Loading

| Twelve months to | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Trend |
|---|---|---|---|---|---|
| Period ending | 30 Sep 25 | 31 Dec 25 | 31 Mar 26 | 30 Jun 26 | Each line by period |
| Revenue | $421.0B | $428.5B | $435.5B | $442.8B | |
| Cost of revenue | −$325.6B | −$331.7B | −$338.0B | −$344.5B | |
| Gross profit | $95.5B | $96.8B | $97.5B | $98.3B | |
| Operating costs | −$42.0B | −$42.7B | −$42.4B | −$42.1B | |
| Cost of products sold | −$17.6B | −$17.9B | −$17.8B | −$17.6B | |
| Depreciation and amortisation | −$8.1B | −$8.3B | −$8.2B | −$8.1B | |
| Restructuring and other charges | −$1.9B | −$1.6B | −$2.3B | −$3.0B | |
| Operating income | $25.9B | $26.3B | $26.9B | $27.4B | |
| Operating margin | 6.1% | 6.1% | 6.2% | 6.2% | |
| Other income and expense, net | −$1.5B | −$1.6B | −$1.7B | −$1.8B | |
| Income before taxes | $24.4B | $24.7B | $25.2B | $25.7B | |
| Income tax expense | −$5.6B | −$5.7B | −$5.8B | −$5.9B | |
| Net income | $18.8B | $19.1B | $19.4B | $19.8B | |
| Diluted shares, billions | 0.93 | 0.93 | 0.92 | 0.92 | |
| Diluted earnings per share | $20.19 | $20.57 | $21.10 | $21.49 | |
| Derived metrics | |||||
| Revenue growth, period on period | no prior period | +1.8% | +1.6% | +1.7% | |
| Gross margin | 22.7% | 22.6% | 22.4% | 22.2% | |
| Net margin | 4.5% | 4.4% | 4.5% | 4.5% | |
Billions of dollars, except earnings per share in dollars and the share count in billions. Growth is on the period before.